The abstract is read at the publisher; the summary is JClub's.
C12RP7 is a protease-resistant lipopeptide that shows potent broad-spectrum antimicrobial activity against 20 tested strains, with TI = 64.20 and low toxicity.
- Why it matters: Antibiotic resistance limits conventional therapies, while antimicrobial peptides often fail due to proteolytic instability and inadequate potency.
- What they did: The team combined an anti-proteolytic Arg-Pro scaffold with N-terminal fatty acid modification, synthesized lipopeptides, and screened them for efficacy, stability, and cytotoxicity.
- The result: In murine peritonitis and enteritis models, C12RP7 reduced bacterial burden, attenuated systemic inflammation, restored intestinal barrier integrity, and modulated gut microbiota.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.